Drug Shortage Report for SANDOZ RISEDRONATE

Last updated on 2018-12-06 History
Report ID 64126
Drug Identification Number 02327295
Brand name SANDOZ RISEDRONATE
Common or Proper name RISEDRONATE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) RISEDRONATE SODIUM
Strength(s) 35MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 1x4Bl
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-09-04
Estimated end date 2018-12-07
Actual end date 2018-12-05
Shortage status Resolved
Updated date 2018-12-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2018-12-06 English Compare
v6 2018-12-05 French Compare
v5 2018-12-05 English Compare
v4 2018-11-04 French Compare
v3 2018-11-04 English Compare
v2 2018-10-15 French Compare
v1 2018-10-15 English Compare

Showing 1 to 7 of 7